Discovery of Amodiachins, a Novel Class of 4-Aminoquinoline Antimalarials Active against Multidrug-Resistant Plasmodium falciparum
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c00936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Mason J Handford und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Physiology and Biochemistry Department, Oregon Health & Science University, 3181 SW Sam Jackson Boulevard, Portland, Oregon 97239, United St…. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, Drug Resistance, Multiple, Aminoquinolines. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIAID NIH HHS, U.S. Department of Veterans Affairs.
Abstract (Originalsprache)
A structure activity relationship study was conducted to optimize metabolic stability and in vivo activity of amodiaquine analog antimalarials. Antiplasmodial activity of synthesized amodiachins (ADCs) were evaluated against drug-sensitive and drug-resistant strains of Plasmodium falciparum. Select compounds were tested in Plasmodium yoelli murine models. Structural modifications, including introduction of a piperidine ring and varied N-alkyl substitutions enhanced antiparasitic activity, metabolic stability, and in vivo efficacy. Compound 43 (ADC-028) emerged as a standout candidate, exhibiting nanomolar activity against drug-sensitive and multidrug-resistant P. falciparum, minimal cytotoxicity, and favorable murine microsomal stability (t1/2 = 48.2 min). In vivo, 43 achieved a nonrecrudescence dose at 16 mg/kg/d and a single dose cure at 50 mg/kg. Pharmacokinetic analysis of 43 showed excellent metabolic stability (T1/2 = 84 h) and oral bioavailability (F = 76%). This study identifies 43 as a potential candidate for further evaluation as a novel compound to overcome drug-resistant malaria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chemical Physiology and Biochemistry Department, Oregon Health & Science University, 3181 SW Sam Jackson Boulevard, Portland, Oregon 97239, United States.
- Portland VA Medical Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, United States.
- Department of Chemistry, Portland State University, 1825 SW Broadway, Portland, Oregon 97201, United States.
- Molecular Microbiology and Immunology Department, Oregon Health & Science University, 3181 SW Sam Jackson Boulevard, Portland, Oregon 97239, United States.
ORCID-Profile: Mason J Handford, Jane X Kelly, Michael K Riscoe
Förderung
- BLRD VA
- NIAID NIH HHS
- U.S. Department of Veterans Affairs
- National Institute of Allergy and Infectious Diseases
- U.S. Department of Defense
- Open Philanthropy Project
Zitieren
APA
Handford, M. J., Li, Y., Riscoe, T., Liebman, K. M., Zhang, X., Kelly, J. X., & Riscoe, M. K. (2025). Discovery of Amodiachins, a Novel Class of 4-Aminoquinoline Antimalarials Active against Multidrug-Resistant Plasmodium falciparum. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00936
Vancouver
Handford MJ, Li Y, Riscoe T, Liebman KM, Zhang X, Kelly JX, et al. Discovery of Amodiachins, a Novel Class of 4-Aminoquinoline Antimalarials Active against Multidrug-Resistant Plasmodium falciparum. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00936
BibTeX
@article{Handford2025,
author = {Handford, Mason J and Li, Yuexin and Riscoe, Teresa and Liebman, Katherine M and Zhang, Xiaowei and Kelly, Jane X and Riscoe, Michael K},
title = {Discovery of Amodiachins, a Novel Class of 4-Aminoquinoline Antimalarials Active against Multidrug-Resistant Plasmodium falciparum},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c00936}
}
EUVIMED